BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy

  Caribou Biosciences, Inc. announced initial results demonstrating a 100% overall response rate and 80% complete response rate in cohort 1 from its ANTLER Phase 1 trial for CB-010 in patients with relapsed or refractory B cell non-Hodgkin lymphoma.

  May 12, 2022

   · 

  9 min read
• Business

  Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update

  Motus GI Holdings, Inc. reported its financial results for the first quarter ended March 31, 2022, and provided a corporate update.

  May 12, 2022

   · 

  9 min read
• Business

  Vincerx Pharma Reports First Quarter 2022 Financial Results and Provides a Corporate Update

  Vincerx Pharma, Inc. reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.

  May 12, 2022

   · 

  9 min read
• Business

  Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

  Bolt Biotherapeutics, Inc. reported financial results for the first quarter ended March 31, 2022 and provided an update on recent business highlights.

  May 12, 2022

   · 

  13 min read
• Business

  Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results

  Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, reported important corporate events and its financial results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  9 min read
• Business

  Jasper Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

  Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic stem cell therapies, announced first quarter 2022 financial results and provided a corporate update.

  May 12, 2022

   · 

  14 min read
• Drug Development

  Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates

  Athira Pharma, Inc. announced the company’s financial results for the quarter ended March 31, 2022 and provided pipeline and business updates.

  May 12, 2022

   · 

  14 min read
• Business

  Adverum Biotechnologies Reports First Quarter 2022 Financial Results

  Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, reported financial results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  9 min read
• Business

  Eyenovia Reports First Quarter 2022 Financial Results

  Eyenovia, Inc., a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology, announced its financial and operating results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  11 min read
• Business

  Neovasc Announces First Quarter Financial Results and Provides Corporate Update

  Neovasc Inc. reported financial results for the quarter ended March 31, 2022.

  May 12, 2022

   · 

  8 min read